B-Right RealEstate specializes in the redevelopment of aging residential societies and slum rehabilitation projects in the Mumbai Metropolitan Region, generating revenue through the sale of residential and commercial units.
The company lacks a structural moat, as evidenced by an average ROCE of 5.5% and ROE of 5.0%, which are below the typical cost of capital for the real estate sector. While high net margins are reported, they appear to be a function of accounting recognition timing rather than durable pricing power or cost advantages.
Earnings are primarily reinvested into new project acquisitions and joint ventures. The company maintains a conservative debt-to-equity ratio of 0.25, but the low return on capital suggests that reinvested funds are not yet generating significant shareholder value.
The investment collapsed as the disconnect between accounting profits and actual capital efficiency became unsustainable. The revolving door of executive leadership eventually led to a breakdown in project execution and internal controls, while the high concentration of promoter ownership prevented any outside intervention. As the cost of capital rose, the company's meager 5.5% ROCE proved insufficient to cover its obligations, forcing a liquidation of assets at distressed prices to repay public fixed deposits, leaving minority shareholders with a permanent loss of capital.
RichFakir rates B-Right RealEstate Ltd's business quality as poor — 36/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, B-Right RealEstate Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on B-Right RealEstate Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of B-Right RealEstate Ltd's fair value is about ₹48 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →